Gerresheimer AG has started the financial year 2008 with an outstanding first quarter. Sales grew by 18.2% compared with the prior year period to €239.1m (2007: €202.3m). Excluding exchange-rate effects, sales actually rose by 21.8%. The operating result (Adjusted EBITDA) also improved again, increasing by 20.4% to €43.0m (prior year period: €35.7m). The Adjusted EBITDA margin therefore reached 18.0% in the first quarter (December 2007 – February 2008), which is seasonally the weakest quarter over the course of the year. The adjusted net income, which shows the operating strength of the company, almost quadrupled to €9.9m (prior year period: €2.6m). The net income improved by €6.5m to €2.5m (prior year period: €-4.0m). Overall, Gerresheimer profited primarily from the high level of demand in the pharma & life science segment, where the company achieves three quarters of its total sales.
Read Article
